Global Implantable Heart Failure Devices Market Growth 2024-2030

Maintaining heart function requires regular ECG rhythm and effective myocardial contraction to ensure adequate blood circulation. Heart failure may occur due to abnormal cardiac structure (such as myocardial or valvular problems), irregular ECG rhythm and decreased myocardial contractility, all of which may lead to reduced pumping efficiency.

The goal of heart failure device treatment is to intervene in these three functional disorders. This usually includes repairing or improving heart structure through anatomical means, using electrophysiological techniques to manage arrhythmias, or enhancing myocardial contractility through mechanical support to improve the heart's pumping function. At the same time, since most heart failures start with left ventricular dysfunction, causing pulmonary congestion, heart failure patients may also experience respiratory failure. Therefore, mechanical support devices can also assist respiratory function and help relieve heart failure symptoms.

According to the treatment principle of the device, the existing heart failure devices on the market can be divided into three categories:

• Mechanical assistance
• Electrical-related technology
• Structural improvement

In the future, with the influence of factors such as doctor recognition, accelerated population aging and improved affordability, the market for heart failure devices will further expand.

The global Implantable Heart Failure Devices market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Implantable Heart Failure Devices Industry Forecast” looks at past sales and reviews total world Implantable Heart Failure Devices sales in 2023, providing a comprehensive analysis by region and market sector of projected Implantable Heart Failure Devices sales for 2024 through 2030. With Implantable Heart Failure Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Implantable Heart Failure Devices industry.

This Insight Report provides a comprehensive analysis of the global Implantable Heart Failure Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Implantable Heart Failure Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Implantable Heart Failure Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Implantable Heart Failure Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Implantable Heart Failure Devices.

The United States market for Implantable Heart Failure Devices is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

The China market for Implantable Heart Failure Devices is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

The Europe market for Implantable Heart Failure Devices is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Implantable Heart Failure Devices players cover:

• Abbott
• Medtronic
• Jarvik Heart
• Abiomed
• Boston Scientific

In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Implantable Heart Failure Devices market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Mechanical Assistance Type
• Electrical Related Technology
• Structural Improvement Type

Segmentation by Application:

• GradeⅠ- Ⅳ
• Grade Ⅱ- Ⅳ
• Grade Ⅲ -IV

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration:

• Abbott
• Medtronic
• Jarvik Heart
• Abiomed
• Boston Scientific
• Impulse Dynamics
• SynCardia
• Berlin Heart
• Covia Medica
• V-Wave
• Evaheart
• BrioHealth Solutions
• Hanyu Medical
• NewMed Medical
• Valgen Medtech

Key Questions Addressed in this Report:

1. What is the 10-year outlook for the global Implantable Heart Failure Devices market?
2. What factors are driving Implantable Heart Failure Devices market growth, globally and by region?
3. Which technologies are poised for the fastest growth by market and region?
4. How do Implantable Heart Failure Devices market opportunities vary by end market size?
5. How does Implantable Heart Failure Devices break out by Type, by Application?